Clinical Trial Update: Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is exploring the mechanism by which ketamine may exert antidepressant effects in treatment-resistant major depression, focusing on the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Depression, Major Depressive Disorder | Phase 1 | Status: RECRUITING